Alpha-Tomatine Inhibits Human Oral Epidermoid Carcinoma Cells Through DNA Damage and Activation of Apoptotic
Nihal Ahamed Abulkalam Azad1, Suresh Kathiresan1, Theerthu Azhamuthu1
1Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Tamil Nadu, India.
Abstract:
Oral cancer still poses a serious threat to world health and has limited feasible remedies. Recently, Alpha-tomatine (AT), a naturally occurring glycoalkaloid, has attracted attention due to its possible anticancer effects. The study investigates its cytotoxic and apoptotic impact of AT against KB human oral carcinoma cells and examine its role in regulating molecular mechanism, with an emphasis on oxidative stress and DNA damage-mediated apoptosis. The MTT assay for cytotoxicity of AT against KB cells showed an IC50 of 11.8 µM. The DCFH-DA staining technique was used to measure ROS formation, and the results indicated a notable, concentration-dependent rise in ROS levels. AO/EtBr and DAPI staining determined the apoptotic morphological alterations, and the comet assay measured the DNA damage of treated cells. Western blot analysis showed a significant downregulation of the anti-apoptotic protein Bcl-2 and an elevation of pro-apoptotic markers include p53, Bax, caspase-3, and caspase-9. Overall, the data indicates that AT triggers apoptosis in KB cell lines by promoting ROS production, p53 activation, and mitochondrial-mediated pathways, leading to DNA fragmentation and caspase-dependent apoptosis. According to these results, AT could serve as a promising candidate or anticancer agent for oral cancer.
Insights
Alpha-tomatine (AT) shows promise as an oral cancer treatment. This natural compound induces cancer cell death through oxidative stress and DNA damage, activating key apoptosis pathways.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Oral cancer remains a significant global health challenge with limited treatment options.
- Alpha-tomatine (AT), a natural glycoalkaloid, exhibits potential anticancer properties.
- Investigating novel therapeutic agents for oral carcinoma is crucial.
Purpose of the Study:
- To evaluate the cytotoxic and apoptotic effects of Alpha-tomatine (AT) on KB human oral carcinoma cells.
- To elucidate the molecular mechanisms underlying AT-induced apoptosis, focusing on oxidative stress and DNA damage.
- To explore AT's potential as an anticancer agent for oral cancer.
Main Methods:
- Cytotoxicity was assessed using the MTT assay, determining the IC50 value.
- Reactive Oxygen Species (ROS) generation was measured via DCFH-DA staining.
- Apoptosis was evaluated through AO/EtBr and DAPI staining, comet assay for DNA damage, and Western blot analysis for protein expression.
Main Results:
- AT demonstrated significant cytotoxicity against KB cells with an IC50 of 11.8 µM.
- AT treatment led to a concentration-dependent increase in ROS levels and induced morphological changes indicative of apoptosis.
- Western blot analysis revealed downregulation of Bcl-2 and upregulation of p53, Bax, caspase-3, and caspase-9.
Conclusions:
- Alpha-tomatine effectively triggers apoptosis in oral cancer cells via ROS production and p53 activation.
- AT-induced apoptosis involves mitochondrial-mediated pathways, leading to DNA fragmentation and caspase activation.
- AT presents a promising therapeutic candidate for oral cancer treatment.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Mutagenicity and Carcinogenicity
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Abnormal Proliferation
The Extrinsic Apoptotic Pathway

